Cargando…

The Conceptual Framework of Dual Disorders and Its Flaws

When psychiatric illness and substance use disorder coexist, the clinical approach to the patient is, unsurprisingly, awkward. This fact is due to a cultural context and, more directly, to the patient’s psychiatric condition and addiction behaviors—a situation that does not favor a scientific approa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacini, Matteo, Maremmani, Angelo G. I., Maremmani, Icro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408800/ https://www.ncbi.nlm.nih.gov/pubmed/32635296 http://dx.doi.org/10.3390/jcm9072098

Ejemplares similares

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health
por: Lovrecic, Barbara, et al.
Publicado: (2019)

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later
por: Pani, Pier Paolo, et al.
Publicado: (2020)

Trends of Hospitalization for Acute Alcohol Intoxication in Slovenian Children and Adolescents with and without Dual Disorder. Implications for a Correct Intervention
por: Lovrecic, Mercedes, et al.
Publicado: (2020)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2012)

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
por: Spera, Vincenza, et al.
Publicado: (2020)

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
por: Maremmani, Angelo G. I., et al.
Publicado: (2021)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)
por: Maremmani, Icro, et al.
Publicado: (2010)

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
por: Barbuti, Margherita, et al.
Publicado: (2023)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Exploring the Role of Caffeine Use in Adult-ADHD Symptom Severity of US Army Soldiers
por: Cipollone, Giada, et al.
Publicado: (2020)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Randomized Trial on the Effects of a Mindfulness Intervention on Temperament, Anxiety, and Depression: A Multi-Arm Psychometric Study
por: Poli, Andrea, et al.
Publicado: (2022)

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)
por: Maremmani, Angelo G.I., et al.
Publicado: (2017)

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice
por: Clerici, Massimo, et al.
Publicado: (2018)

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder
por: Maremmani, Icro, et al.
Publicado: (2015)

Substance Use/Dependence in Psychiatric Emergency Setting Leading to Hospitalization: Predictors of Continuity of Care
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2022)

Addictive and other mental disorders: a call for a standardized definition of dual disorders
por: Szerman, Nestor, et al.
Publicado: (2022)

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
por: Maremmani, Icro, et al.
Publicado: (2023)

The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment
por: Maremmani, Angelo G. I., et al.
Publicado: (2016)

Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model
por: Cenci, Davide, et al.
Publicado: (2022)

Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review
por: Caputo, Fabio, et al.
Publicado: (2009)

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
por: Pani, Pier Paolo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a10c8u20mladtgrrr7v580k0er